🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The aim of this study was to evaluate the efficacy, safety and tolerability...
Status
Not Yet Recruiting
Location
Breast Cancer Center Shandong Cancer Hospital and Institute Shandong First Medical University and Shandong Academy of Medical Sciences
Start Date
2025-08-01
Trial ID
NCT07093931
Treatments Being Tested
This is a prospective, randomized study to compare the efficacy of TP (Taxa...
Status
Completed
Location
Xijing Hospital
Start Date
2021-01-01
Trial ID
NCT07115095
Treatments Being Tested
Breast cancer is the second most common invasive malignancy and the leading...
Status
Terminated
Location
Hospital del Mar
Start Date
2022-05-11
Trial ID
NCT05385705
Treatments Being Tested
This is a prospective non-randomized national clinical phase 2 trial that a...
Status
Recruiting
Location
Turku University Hospital Cancer Centre
Start Date
2021-12-10
Trial ID
NCT05159245
Currently there are five trastuzumab biosimilars approved by EMA (Ogivri® M...
Status
Unknown
Location
Centre de lutte contre le Cancer JEAN PERRIN, CLERMONT-FERRAND
Start Date
2020-12
Trial ID
NCT04644406
Treatments Being Tested
This two-cohort, open-label, multicenter, phase 2 study will assess the saf...
Status
Completed
Location
Multiple Locations
Start Date
2012-04
Trial ID
NCT01565083
Treatments Being Tested
This is a study to compare the similarity in Pharmacokinetics (PK) profile ...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-07-03
Trial ID
NCT07601620
Treatments Being Tested
This is a single-arm, multi-center, open-label extension study designed to ...
Status
Active Not Recruiting
Location
Santa Casa de Misericordia de Porto Alegre
Start Date
2015-02-02
Trial ID
NCT02320435
Treatments Being Tested
This is a randomized, open label Phase II neoadjuvant study comparing the e...
Status
Unknown
Location
ShengJing ospital of China Medical University
Start Date
2021-10-20
Trial ID
NCT05483439
The trial included screening period (4 weeks) and treatment period (4 treat...
Status
Active Not Recruiting
Location
The Affiliated Hospital of Qingdao University
Start Date
2020-06-28
Trial ID
NCT04514419
Treatments Being Tested